News

A toxin produced by E. coli may be driving rates of bowel cancer in young people in the United Kingdom, scientists have discovered.Experts believe the finding could help explain why rates of bowel ...
The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...
Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.
Tina Knowles’ breast cancer diagnosis highlights a critical issue: many early-stage cancers are only caught through routine screenings.
New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...
Researchers at the Viterbi School of Engineering published a study at the beginning of April detailing their work using ...
AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...
A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, ...
Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...
Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...
A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...